Trial Profile
Efficacy and safety of Fixed-Dose Combination (FDC) products containing trazodone and gabapentin in patients affected by painful diabetic neuropathy: randomized, controlled, dose finding study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 May 2021
Price :
$35
*
At a glance
- Drugs Gabapentin/trazodone (Primary) ; Gabapentin
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- Sponsors Angelini Group
- 26 May 2021 Status changed from recruiting to completed.
- 09 Oct 2020 This trial has been completed in Poland according to European Clinical Trials Database record.
- 15 Jul 2020 This trial has been completed in Czech Republic according to European Clinical Trials Database record.